Share on

Global Head & Neck Cancer Diagnostics Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Test Type and Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 33
Pages: 175
Formats: report pdf report excel report power bi report ppt

Head and Neck Cancer Diagnostics Market Size (2022 to 2027)

The global head and neck cancer diagnostics market is predicted to grow significantly, at a CAGR of nearly 11.52% during the forecast period. The market has evolved significantly in developed countries. It has enormous prospects in emerging countries such as India, China, Indonesia, and Thailand. In addition, the rising market demand for diagnostic imaging, advances in treatment modes, and incorporation of novel technologies in diagnostic equipment will further propel the market growth during the forecast period.

Head and Neck cancer is among the ten most common types of cancers worldwide, and these forms of cancer are especially prevalent in regions of high alcohol and tobacco intake across the globe. Early detection and prompt treatment offer the best chance for cure of these diseases. The rising number of diagnostic procedures for head and neck cancer, particularly pharyngeal and oral cancers, are few factors inducing the market growth.

MARKET DRIVERS:

Rising disposable income leading to increased human healthcare expenditure, increasing demand for diagnostic imaging, advancements in treatment modes, and incorporating new technologies in diagnostic equipment will further drive the market growth during the forecast period. Due to the increase in personal health care spending in the United States, the health industry in the region is growing rapidly, resulting in the growth of the cancer diagnostics market head and neck.

Personal health spending in the United States has seen a significant increase over the past decade, from $ 2.010 billion in 2010 to $ 3,979 billion in 2020, resulting in an average annual percentage change of 5.2% during this period, according to as reported by the CDC. Hospital spending accounted for the largest share, with 42.3% of total personal health care spending in the United States in 2020. Next are medical and clinical expenditures, prescription drugs, and dental care, which accounted for a 24.8% share, 13.7%, and 5.6%, respectively. It is estimated that the propensity of the population to spend on this industry in exchange for improved technologies and advanced treatment methods and dental and hospital care will drive the growth of the global market for head and neck cancer diagnostic region by the end of 2025.

Adopting a sedentary lifestyle and changes in food habits is a significant factor driving the market demand. Increasing incidences of chronic diseases such as cancer are also thriving the growth of the market. Growing concern towards health and the need for early diagnosis of the issues significantly influence the demand of the market. Head and neck cancer diagnostics are anticipated to have a tremendous growth rate. The increasing need for targeted therapies and growing awareness over the availability of various treatment procedures is leveraging the market's growth. The rising geriatric population across the world is ascribed to outshine the demand of the market.

Increasing support from private and public organizations through investments is solely to surge growth opportunities for the market. Increasing the intake of alcohol and tobacco products, especially in well-developed countries, is fuelling the demand of the head and neck cancer diagnostics market. The rise in the need to live a healthy lifestyle by diagnosing the diseases early as it has a permanent cure is also ascribed to bolster the market demand extensively. Furthermore, the launch of innovative imaging techniques in the medical sector is significantly influencing the market's growth.

MARKET RESTRAINTS:

However, the Lack of skilled physicians in analyzing the reports accurately is slowly impeding the market demand. The cost of installing the devices is very high, which cannot be affordable by small scale industries is limiting the growth of the market. Frequent changes in software technologies may also hamper the development of the head and neck cancer diagnostics market. Along with this, a rise in the number of risks due to the failure of systems in the real-time application limits the growth rate of this market. Also, rapid changes in economic strategies are inhibiting the demand of the market.

Impact of COVID-19 on the global heck and neck cancer diagnostics market:

The World Health Organization (WHO) announced COVID 19 as an emergency public health issue. During the COVID 19 epidemic, head and neck cancer patients' treatment and diagnosis have been greatly affected. The COVID 19 pandemic creates challenges in the management of patients with head and neck cancer. Cancer treatments were canceled or postponed during the lockdown period where emergency care patients got treatment with utmost care. Cancer patients face significant difficulties in disease diagnosis and treatment. During this period, the hospitals are high-risk areas for spreading the disease, and cancer patients may easily be exposed to viral infections. Telemedicine may play a vital role in the primary assessment of signs and symptoms for cancer patients. However, the market is expected to fall soon in the normal position and register its regular growth rate by the end of 2021.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

By Test Type and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global head and neck cancer diagnostics market has been segmented and sub-segmented into the following categories:

Head & Neck Cancer Diagnostics Market - By Test Type:

  • Diagnostic Imaging              
    • PET/CT
    • MRI
    • X-Ray
    • Barium Swallow Test
  • Biopsy       
    • Incisional Biopsy
    • Fine Needle Aspiration Biopsy
    • HPV Testing
  • Endoscopy              
    • Pharyngoscopy
    • Laryngoscopy
    • Panendoscopy
  • Dental Diagnostics
    • Fluorescence Visualization
    • Toluidine Blue Dye-Based Method
    • Acetic Acid Rinse Method
    • Brush Biopsy

Based on the type, the diagnostic imaging segment is leading with the highest shares of the market. Growing awareness of the benefits of early diagnosis is likely to propel the growth of the market. A rise in the availability of various treatment procedures magnifies the demand of the head & neck cancer diagnostics market. Increasing the scale of diagnostic cancer with the latest equipment is lavishing the growth rate of the need to the extent. People demand effective treatment procedures at any cost and ensure the well-being of a patient after treatment is outshining the market's demand to the extent. Besides, increasing economic strength in well developed and developing countries is prompting the need of the market. The Head & neck cancer diagnostics market is fueled by growing concern towards the patient’s health condition and government plans to decrease the cost of treatment procedures in hospitals.

Head & Neck Cancer Diagnostics Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the global head and neck cancer diagnostics market is expected to increase year on year with an increased incidence of the disease. North America is holding the highest shares of the market owing to the quick acceptance of advanced technologies in every field. Increasing capital income in both developed and developing countries are escalating the growth of the market in this region. Though this form of cancer is not prevalent in all its forms in the US, it has increased presence and incidence in Asia, Africa, and Europe, making its screening and early detection of high importance to affect proper treatment and care. Accurate detection at an early stage can lead to appropriate treatment and a long, healthier life.

Europe is following North America is leading the shares of the market with the rise in the government initiatives in favor of the ordinary people by launching reimbursement schemes. 

In recent years, Asia Pacific has had the fastest growth rate and is expected to register the highest CAGR from 2020 to 2025. The increasing geriatric population is undoubtedly a primary factor for the market to grow. The growing economy in most countries is gearing up the demand of the market in this region.

Latin America is anticipated to have a slight inclination in the growth rate shortly. Growing prevalence to have an adequate diagnosis to have appropriate treatment procedures for the diseases impacts the market's demand towards positive.

The Middle East and Africa are projected to have substantial growth opportunities in foreseen years with the increasing scale of the healthcare centers with the latest equipment.

KEY MARKET PARTICIPANTS:

Some of the notable companies operating in the global head and neck diagnostics market profiled in this report are Philips Healthcare, Varian Medical Systems, Siemens Healthcare, GE Healthcare, Shimadzu Corporation, Identafi, Velscope VX, and AdDent Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample